[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (9,815)

Search Parameters:
Keywords = wound

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
25 pages, 34340 KiB  
Article
Establishment and Verification of a Novel Gene Signature Connecting Hypoxia and Lactylation for Predicting Prognosis and Immunotherapy of Pancreatic Ductal Adenocarcinoma Patients by Integrating Multi-Machine Learning and Single-Cell Analysis
by Ying Zheng, Yang Yang, Qunli Xiong, Yifei Ma and Qing Zhu
Int. J. Mol. Sci. 2024, 25(20), 11143; https://doi.org/10.3390/ijms252011143 - 17 Oct 2024
Abstract
Pancreatic ductal adenocarcinoma (PDAC) has earned a notorious reputation as one of the most formidable and deadliest malignant tumors. Within the tumor microenvironment, cancer cells have acquired the capability to maintain incessant expansion and increased proliferation in response to hypoxia via metabolic reconfiguration, [...] Read more.
Pancreatic ductal adenocarcinoma (PDAC) has earned a notorious reputation as one of the most formidable and deadliest malignant tumors. Within the tumor microenvironment, cancer cells have acquired the capability to maintain incessant expansion and increased proliferation in response to hypoxia via metabolic reconfiguration, leading to elevated levels of lactate within the tumor surroundings. However, there have been limited studies specifically investigating the association between hypoxia and lactic acid metabolism-related lactylation in PDAC. In this study, multiple machine learning approaches, including LASSO regression analysis, XGBoost, and Random Forest, were employed to identify hub genes and construct a prognostic risk signature. The implementation of the CERES score and single-cell analysis was used to discern a prospective therapeutic target for the management of PDAC. CCK8 assay, colony formation assays, transwell, and wound-healing assays were used to explore both the proliferation and migration of PDAC cells affected by CENPA. In conclusion, we discovered two distinct subtypes characterized by their unique hypoxia and lactylation profiles and developed a risk score to evaluate prognosis, as well as response to immunotherapy and chemotherapy, in PDAC patients. Furthermore, we indicated that CENPA may serve as a promising therapeutic target for PDAC. Full article
(This article belongs to the Section Molecular Immunology)
Show Figures

Figure 1

Figure 1
<p>Identification of prognostic hypoxia- and lactylation-related genes (HALRGs) and mutation landscape. (<b>A</b>) Intersection of differentially expressed genes (DEGs) in PDAC samples with hypoxia- and lactylation-related genes. (<b>B</b>) Univariate Cox analysis of these genes. (<b>C</b>) Biological network integration of these prognostic genes analyzed by GeneMANIA. (<b>D</b>) Kaplan–Meier survival curve of certain prognostic genes.</p>
Full article ">Figure 2
<p>Pan-cancer analysis of the prognostic hypoxia- and lactylation-related genes. (<b>A</b>) Survival differences between high and low GSVA score groups across various cancers. (<b>B</b>) Association between GSVA scores and cancer-related pathway activity (*: <span class="html-italic">p</span>-value ≤ 0.05; #: FDR ≤ 0.05). (<b>C</b>,<b>D</b>) Summary of the relationship between gene expression and responsiveness of top 30 GDSC and CTRP drugs in the pan-cancer analysis.</p>
Full article ">Figure 3
<p>Unsupervised clustering analysis identified two PDAC subtypes with distinctive biological functional characteristics in the TCGA and GSE183795 cohorts. (<b>A</b>) Consensus matrix heatmap defining two subtypes (k = 2). (<b>B</b>) PCA indicating the significant differences in transcriptomes between the subtypes. (<b>C</b>) Survival analysis indicates cluster A has a poor prognosis compared to cluster B. (<b>D</b>) Using PROGENy (Pathway RespOnsive GENes for activity inference) to assess the pathway activation in the above two subtypes (ns <span class="html-italic">p</span> &gt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; **** <span class="html-italic">p</span> &lt; 0.0001). (<b>E</b>) KEGG enrichment analysis of the two subtypes. (<b>F</b>) GO enrichment analysis of the two subtypes.</p>
Full article ">Figure 4
<p>Identification of hub genes using various machine learning algorithms, and construction of a hypoxia- and lactylation-related prognostic signature for PDAC. (<b>A</b>,<b>B</b>) LASSO Cox regression was used to identify signature genes and develop a prognostic module for PDAC patients. (<b>C</b>) Bar graph of the coefficient index of the hub genes. (<b>D</b>) Heatmap of hub gene expression in the low- and high-risk groups. (<b>E</b>,<b>F</b>) Risk score distribution and survival status in the two risk groups. (<b>G</b>) Kaplan–Meier survival curve showing overall survival (OS) in the two risk groups. (<b>H</b>) ROC curves predicting the sensitivity and specificity of the risk score model for the 1-, 3-, and 5-year survival rates. (<b>I</b>) Time-dependent ROC analysis indicating the predictive power of the risk signature and other clinical characteristics. (<b>J</b>,<b>K</b>) Mutation landscape of the low- and high-risk groups.</p>
Full article ">Figure 5
<p>Validation of the prognostic module in independent external datasets (GSE62452, GSE78299, and GSE85916) and nomogram construction. (<b>A</b>–<b>C</b>) Kaplan–Meier analysis validating the predictive power of the prognostic model in the GSE62452, GSE78299, and GSE85916 datasets. (<b>D</b>–<b>F</b>) ROC curves demonstrating the sensitivity and specificity of the risk score model for the 1-, 3-, and 5-year survival rates in these test cohorts. (<b>G</b>,<b>H</b>) Nomogram construction integrating the risk score and clinical characteristics (* <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01). (<b>I</b>,<b>J</b>) Forest plots of the univariate and multivariate Cox regression analyses show that the risk score is an independent prognostic factor for PDAC in the training cohort.</p>
Full article ">Figure 6
<p>The immunogenomic landscape of signature genes and their predictive values for immunotherapy and chemotherapy. (<b>A</b>) Correlation between risk scores and immune cell abundance analyzed using various immune cell profiling methods. (<b>B</b>) Evaluation of the potential efficacy of immunotherapy in low- and high-risk groups, showing a less favorable response in the high-risk group.(*** <span class="html-italic">p</span> &lt; 0.001) (<b>C</b>) Correlation analysis between signature genes and genes associated with immune evasion. (<b>D</b>) Analysis of chemotherapeutic sensitivity between the low- and high-risk groups (*** <span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 7
<p>CERES score of signature genes and HAL score analysis at the single-cell level. (<b>A</b>) CERES score of signature genes. (<b>B</b>) UMAP-1 plot showing cell subtypes identified from scRNA-seq data. (<b>C</b>) Distribution of <span class="html-italic">CENPA</span> in metastasis, normal, and primary PADC scRNA samples. (<b>D</b>) Heatmap displaying variations in interaction numbers. (<b>E</b>) Bar graph showing key signaling pathways differing between the high- and low-scoring groups. (<b>F</b>) Circular plot visualizing differences in cell–cell communication networks between the high- and low-scoring groups.</p>
Full article ">Figure 8
<p>The expression profile of <span class="html-italic">CENPA</span> in PDAC; the knockdown of <span class="html-italic">CENPA</span> hampers the proliferation and migratory potential of PDAC cells. (<b>A</b>) Validation of <span class="html-italic">CENPA</span> expression in the HPA database. (<b>B</b>) The expression level of <span class="html-italic">CENPA</span> in the PDAC expression data cohort from the TCGA and GETx database. (<b>C</b>) Associations between <span class="html-italic">CENPA</span> expression and overall survival of PDAC patients. (<b>D</b>) Relative mRNA expression of <span class="html-italic">CENPA</span> in PDAC cell lines (BXPC-3, CAPAN-1, CAPAN-2, CFPAC-1, MIA PaCa-2, PANC-1, and SW1990) and HPDE normal pancreatic ductal epithelial cells. (<b>E</b>) <span class="html-italic">CENPA</span> knockdown in PANC-1 and MIA PaCa-2 cells verified by qRT-PCR and Western blot. The cck8 assay (<b>F</b>) and colony formation assay (<b>G</b>) show reduced cell viability in <span class="html-italic">CENPA</span> knockdown PANC-1 and MIA PaCa-2 cells. (<b>H</b>,<b>I</b>) Wound-healing and transwell assays indicate significantly reduced migration ability in <span class="html-italic">CENPA</span> knockdown PANC-1 and MIA PaCa-2 cells. <span class="html-italic">n</span> = 3, ns <span class="html-italic">p</span> &gt; 0.05, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001. Error bars represent mean ± SD.</p>
Full article ">Figure 9
<p>Correlation between <span class="html-italic">CENPA</span> expression and drug sensitivity, and molecular docking of drugs correlated with the high expression of <span class="html-italic">CENPA</span>. (<b>A</b>) Correlation analysis between <span class="html-italic">CENPA</span> expression and drug sensitivity, conducted using BEST. (<b>B</b>) Molecular docking diagrams of <span class="html-italic">CENPA</span> with the two drugs showing the strongest binding affinity: betulinic acid (−8.1 kcal/mol) and GSK2126458 (−8.6 kcal/mol).</p>
Full article ">
20 pages, 1417 KiB  
Review
Molecular and Cellular Mechanisms of the Therapeutic Effect of Mesenchymal Stem Cells and Extracellular Vesicles in Corneal Regeneration
by Nina Kobal, Miha Marzidovšek, Petra Schollmayer, Elvira Maličev, Marko Hawlina and Zala Lužnik Marzidovšek
Int. J. Mol. Sci. 2024, 25(20), 11121; https://doi.org/10.3390/ijms252011121 - 16 Oct 2024
Viewed by 266
Abstract
The cornea is a vital component of the visual system, and its integrity is crucial for optimal vision. Damage to the cornea resulting from trauma, infection, or disease can lead to blindness. Corneal regeneration using mesenchymal stem cells (MSCs) and MSC-derived extracellular vesicles [...] Read more.
The cornea is a vital component of the visual system, and its integrity is crucial for optimal vision. Damage to the cornea resulting from trauma, infection, or disease can lead to blindness. Corneal regeneration using mesenchymal stem cells (MSCs) and MSC-derived extracellular vesicles (MSC-EVs) offers a promising alternative to corneal transplantation. MSCs are multipotent stromal cells that can differentiate into various cell types, including corneal cells. They can also secrete a variety of anti-inflammatory cytokines and several growth factors, promoting wound healing and tissue reconstruction. This review summarizes the current understanding of the molecular and cellular mechanisms by which MSCs and MSC-EVs contribute to corneal regeneration. It discusses the potential of MSCs and MSC-EV for treating various corneal diseases, including corneal epithelial defects, dry eye disease, and keratoconus. The review also highlights finalized human clinical trials investigating the safety and efficacy of MSC-based therapy in corneal regeneration. The therapeutic potential of MSCs and MSC-EVs for corneal regeneration is promising; however, further research is needed to optimize their clinical application. Full article
(This article belongs to the Special Issue Recent Advances in Molecular and Cellular Research in Ophthalmology)
Show Figures

Figure 1

Figure 1
<p>Schematic cross-section of a human eye with an expanded view of the cornea.</p>
Full article ">Figure 2
<p>Various corneal pathologies can lead to corneal edema and opacification (<b>A</b>,<b>B</b>), which is conventionally treated by surgical removal and donor corneal transplantation (penetrating (<b>C</b>) and lamellar keratoplasties (<b>D</b>)). (<b>A</b>) Bullous keratopathy and corneal scar years after penetrating injury and (<b>C</b>) 1 month after PK. (<b>B</b>) Bullous keratopathy years after cataract surgery and (<b>D</b>) 1 month after DMEK. (<b>E</b>) A schematic representation of different types of corneal transplantation techniques. The blue section represents the recipient cornea and the yellow section in the red square–dot line represents the transplanted donor corneal graft tissue. In PK, all corneal layers are transplanted, whereas in DALK, only the anterior corneal layers are transplanted. Posterior lamellar techniques involve selective removal of the patient’s Descemet membrane (DM) and endothelium, which is followed by either the transplantation of the donor corneal endothelium, the DM and a thin stromal layer in DSAEK or by the transplantation of only the donor DM and the endothelium in DMEK. Abbreviations: PK—penetrating keratoplasty; DALK—deep anterior lamellar keratoplasty; DSAEK—Descemet’s stripping automated endothelial keratoplasty; DMEK—Descemet’s membrane endothelial keratoplasty.</p>
Full article ">Figure 3
<p>Schematic representation of different regenerative corneal therapies. Abbreviations: LESC—limbal epithelial stem cell; CSSC—corneal stromal stem cell; CEnC—corneal endothelial cell; MSC—mesenchymal stem cell; SC—stem cell; iPSC—induced pluripotent stem cell; AM—amniotic membrane; MSC-EV—extracellular vesicle derived from mesenchymal stem cell; MSC(M)—bone marrow-derived mesenchymal stem cell; MSC(UC)—umbilical cord-derived mesenchymal stem cell.</p>
Full article ">Figure 4
<p>Schematic representation of mesenchymal stem cell-derived extracellular vesicles (such as exosomes, microvesicles and apoptotic bodies), their biogenesis and transfer from cell of origin to recipient cell. They are capable of transferring bioactive molecules to recipient cells through three different mechanisms: endocytosis, specific receptor–ligand interactions and direct fusion. Extracellular vesicles have various effects on corneal cells. Abbreviations: MSC—mesenchymal stem cell; ECM—extracellular matrix; SC—stem cell.</p>
Full article ">
19 pages, 4062 KiB  
Article
Analysis of the Mechanisms Underlying the Specificity of the Variation Potential Induced by Different Stimuli
by Maxim Mudrilov, Maria Ladeynova, Yana Vetrova and Vladimir Vodeneev
Plants 2024, 13(20), 2896; https://doi.org/10.3390/plants13202896 - 16 Oct 2024
Viewed by 254
Abstract
Plants are able to perceive diverse environmental factors and form an appropriate systemic functional response. Systemic responses are induced by stimulus-specific long-distance signals that carry information about the stimulus. Variation potential is proposed as a candidate for the role of such a signal. [...] Read more.
Plants are able to perceive diverse environmental factors and form an appropriate systemic functional response. Systemic responses are induced by stimulus-specific long-distance signals that carry information about the stimulus. Variation potential is proposed as a candidate for the role of such a signal. Here, we focus on the mechanisms that determine the specificity of the variation potential under the action of different local stimuli. Local stimuli such as heating, burning and wounding cause variation potential, the parameters of which differ depending on the type of stimulus. It was found that the stimulus-specific features of the hydraulic signal monitored by changes in leaf thickness and variation potential, such as a greater amplitude upon heating and burning and a significant amplitude decrement upon burning and wounding, were similar. The main features of these signals are the greater amplitude upon heating and burning, and a significant amplitude decrement upon burning and wounding. Together with the temporal correspondence of signal propagation, this evidence indicates a role for the hydraulic signal in the induction of stimulus-specific variation potential. Experiments using mechanosensitive channel inhibitors have demonstrated that the hydraulic signal contributes more to the induction of the variation potential in the case of rapidly growing stimuli, such as burning and wounding, than in the case of gradual heating. For thermal stimuli (gradual heating and burning), a greater contribution, compared to wounding, of the chemical signal related to reactive oxygen species to the induction of the variation potential was demonstrated. Thus, the specificity of the parameters of the variation potential is determined by the different contributions of hydraulic and chemical signals. Full article
Show Figures

Figure 1

Figure 1
<p>Variation potentials (VPs) induced by local heating, burning or wounding in wheat plants. (<b>A</b>) Averaged VP traces. The arrow indicates the moment of mechanical wounding, burning or the beginning of gradual heating of the leaf tip. (<b>B</b>) Dependence of the VP amplitude on the distance to the area of local stimulation. Data are means ± SEM. Different uppercase letters indicate statistically significant differences between stimuli; different lowercase letters indicate statistically significant differences between distances within a single stimulus (<span class="html-italic">p</span> &lt; 0.05). (<b>C</b>) Schematic representation of the experimental design for monitoring surface potentials in wheat plants. E1, E2, E3: surface electrodes.</p>
Full article ">Figure 2
<p>Systemic changes in leaf thickness induced by local heating, burning or wounding in wheat plants. (<b>A</b>) Simultaneous representative recordings of leaf thickness changes (Δh, solid lines) and variation potentials (ΔU, dashed lines) at a distance of 4.5 cm and 3 cm, respectively, from the stimulation area. The arrow indicates the moment of mechanical wounding, burning or the beginning of gradual heating of the leaf tip. (<b>B</b>) Averaged recordings of leaf thickness changes (Δh); shaded regions (envelopes) represent SEM. The arrow indicates the moment of mechanical wounding, burning or the beginning of gradual heating of the leaf tip. (<b>C</b>–<b>E</b>) Dependences of the amplitude (<b>C</b>), duration (<b>D</b>) and rate (<b>E</b>) of leaf thickening on the distance to the area of local stimulation. Data are means ± SEM. Different uppercase letters indicate statistically significant differences between stimuli; different lowercase letters indicate statistically significant differences between distances within a single stimulus (<span class="html-italic">p</span> &lt; 0.05). (<b>F</b>) Schematic representation of the experimental design for simultaneous monitoring of surface potentials and changes in wheat leaf thickness. E1, E2, E3: surface electrodes. Yellow lines are light bands between the sender units and the receiver units of the optical micrometers (gray rectangles).</p>
Full article ">Figure 3
<p>The dynamics of stomatal conductance (g<sub>S</sub>) induced by local heating, burning or wounding in the unstimulated part of the wheat plant. Lines are means; shaded regions (envelopes) represent SEM. The dashed line indicates the moment of generation of the variation potential.</p>
Full article ">Figure 4
<p>Variation potentials (VPs) induced by local heating, burning or wounding in the detached wheat leaf. (<b>A</b>) Averaged VP traces. The arrow indicates the moment of mechanical wounding, burning or the beginning of gradual heating of the leaf tip. (<b>B</b>) Comparison of the dependences of the VP amplitude on the distance to the area of local stimulation in detached leaves (solid lines) and whole wheat plants (dashed lines). Data are means ± SEM. For detached leaves only, different uppercase letters indicate statistically significant differences between stimuli; different lowercase letters indicate statistically significant differences between distances within a single stimulus (<span class="html-italic">p</span> &lt; 0.05). (<b>C</b>) Schematic representation of the experimental design for monitoring surface potentials in wheat plants. E1, E2, E3: surface electrodes.</p>
Full article ">Figure 5
<p>Systemic changes in leaf thickness (Δh) induced by local heating, burning or wounding in the detached wheat leaf. Lines are means; shaded regions (envelopes) represent SEM. The arrow indicates the moment of mechanical wounding, burning or the beginning of gradual heating of the leaf tip.</p>
Full article ">Figure 6
<p>Effects of the reactive oxygen species (ROS) scavenger N,N′-dimethylthiourea (DMTU) and ROS-producing enzyme inhibitors diphenyleneiodonium chloride (DPI) and salicylhydroxamic acid (SHAM) on the amplitudes of the variation potentials (VPs) induced by local heating, burning or wounding in the detached wheat leaf. VP amplitude is represented as the percentage of control, which is the VP amplitude in untreated leaves (without scavengers and inhibitors). Data are means ± SEM. * indicates data significantly different from untreated leaves (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 7
<p>Effects of the H<sup>+</sup>-ATPase inhibitor Na<sub>3</sub>VO<sub>4</sub>, the Са<sup>2+</sup>-permeable channel blocker LaCl<sub>3</sub> and the mechanosensitive channel inhibitor GdCl<sub>3</sub> on the variation potentials (VPs) induced by local heating, burning or wounding in the detached wheat leaf. (<b>A</b>) Averaged VP traces observed at a distance of 6 cm from the stimulation area in untreated leaves (dashed lines) or those treated with the inhibitor/blocker (solid lines). (<b>B</b>–<b>D</b>) VP amplitude at a distance of 6 cm from the area of local stimulation upon treatment with Na<sub>3</sub>VO<sub>4</sub> (<b>B</b>), LaCl<sub>3</sub> (<b>C</b>) or GdCl<sub>3</sub> (<b>D</b>). VP amplitude is represented as the percentage of control, which is the VP amplitude in untreated leaves (without inhibitor). Data are means ± SEM. Statistically significant differences between untreated and treated leaves were found for all stimuli. * indicates significant differences between the stimuli (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
20 pages, 2552 KiB  
Review
Advances and Functional Integration of Hydrogel Composites as Drug Delivery Systems in Contemporary Dentistry
by Dragos Nicolae Fratila, Dragos Ioan Virvescu, Ionut Luchian, Monica Hancianu, Elena Raluca Baciu, Oana Butnaru and Dana Gabriela Budala
Gels 2024, 10(10), 661; https://doi.org/10.3390/gels10100661 - 16 Oct 2024
Viewed by 463
Abstract
This study explores the recent advances of and functional insights into hydrogel composites, materials that have gained significant attention for their versatile applications across various fields, including contemporary dentistry. Hydrogels, known for their high water content and biocompatibility, are inherently soft but often [...] Read more.
This study explores the recent advances of and functional insights into hydrogel composites, materials that have gained significant attention for their versatile applications across various fields, including contemporary dentistry. Hydrogels, known for their high water content and biocompatibility, are inherently soft but often limited by mechanical fragility. Key areas of focus include the customization of hydrogel composites for biomedical applications, such as drug delivery systems, wound dressings, and tissue engineering scaffolds, where improved mechanical properties and bioactivity are critical. In dentistry, hydrogels are utilized for drug delivery systems targeting oral diseases, dental adhesives, and periodontal therapies due to their ability to adhere to the mucosa, provide localized treatment, and support tissue regeneration. Their unique properties, such as mucoadhesion, controlled drug release, and stimuli responsiveness, make them ideal candidates for treating oral conditions. This review highlights both experimental breakthroughs and theoretical insights into the structure–property relationships within hydrogel composites, aiming to guide future developments in the design and application of these multifunctional materials in dentistry. Ultimately, hydrogel composites represent a promising frontier for advancing materials science with far-reaching implications in healthcare, environmental technology, and beyond. Full article
Show Figures

Figure 1

Figure 1
<p>Potential uses of hydrogels in the dental field.</p>
Full article ">Figure 2
<p>Hydrogel characteristics and classification (with IPN—interpenetrating polymer network).</p>
Full article ">Figure 3
<p>The action mechanisms of a smart hydrogel.</p>
Full article ">Figure 4
<p>Structures of hydrogels and nanogels.</p>
Full article ">Figure 5
<p>The pathway of a drug delivery system to treat periodontal disease.</p>
Full article ">
12 pages, 258 KiB  
Article
Effect of Treatment of Neuropathic and Ischemic Diabetic Foot Ulcers with the Use of Local Ozone Therapy Procedures—An Observational Single Center Study
by Jarosław Pasek, Sebastian Szajkowski and Grzegorz Cieślar
Clin. Pract. 2024, 14(5), 2139-2150; https://doi.org/10.3390/clinpract14050169 (registering DOI) - 16 Oct 2024
Viewed by 130
Abstract
Background: Diabetes ranks high among worldwide global health problems, and diabetic foot ulcer syndrome (DFU) is considered as one of its most serious complications. The purpose of this study was to evaluate the impact of local ozone therapy procedures on the wound healing [...] Read more.
Background: Diabetes ranks high among worldwide global health problems, and diabetic foot ulcer syndrome (DFU) is considered as one of its most serious complications. The purpose of this study was to evaluate the impact of local ozone therapy procedures on the wound healing process in patients with two DFU types: neuropathic and ischemic. Material and Methods: In the retrospective study reported here, the treatment outcomes of 90 patients were analyzed: 44 males (48.8%) and 46 females (51.2%), in the age range between 38 and 87 years of age, with neuropathic (group 1) and ischemic (group 2) diabetic foot ulcers treated by means of local ozone therapy. The assessment of therapeutic effects in both groups of patients included an analysis of the rate of ulcer healing using planimetry and an analysis of the intensity of pain associated with ulcers performed using the VAS scale. Results: After the application of ozone therapy procedures, a statistically significant decrease in the surface area of the ulcers was obtained in both groups of patients, respectively: in group 1 from 7 (6–7.5) cm2 to 3 (2–3.5) cm2 and in group 2 from 7.5 (6.5–8) cm2 to 5 (4.5–5.5) cm2 (p < 0.001), with a complete healing of ulcers not observed in any patients from groups 1 and 2. After treatment, the surface area of the assessed ulcers was smaller in the neuropathic group. The intensity of pain experienced after treatment also decreased with statistical significance in both groups (p < 0.001). Conclusions: Short-term local ozone therapy was effective in promoting wound healing and alleviating pain in patients with DFUs of both neuropathic and ischemic etiology. The effectiveness of therapy in the neuropathic type of DFUs was significantly higher than in the ischemic type, in which patients had a higher incidence of risk factors and more advanced lesions, characterized by a larger initial ulcer area and greater intensity of pain. Full article
16 pages, 5120 KiB  
Article
A Polyurethane Electrospun Membrane Loaded with Bismuth Lipophilic Nanoparticles (BisBAL NPs): Proliferation, Bactericidal, and Antitumor Properties, and Effects on MRSA and Human Breast Cancer Cells
by Jesús Alejandro Torres-Betancourt, Rene Hernández-Delgadillo, Juan Valerio Cauich-Rodríguez, Diego Adrián Oliva-Rico, Juan Manuel Solis-Soto, Claudia María García-Cuellar, Yesennia Sánchez-Pérez, Nayely Pineda-Aguilar, Samantha Flores-Treviño, Irene Meester, Sergio Eduardo Nakagoshi-Cepeda, Katiushka Arevalo-Niño, María Argelia Akemi Nakagoshi-Cepeda and Claudio Cabral-Romero
J. Funct. Biomater. 2024, 15(10), 309; https://doi.org/10.3390/jfb15100309 (registering DOI) - 16 Oct 2024
Viewed by 353
Abstract
Electrospun membranes (EMs) have a wide range of applications, including use as local delivery systems. In this study, we manufactured a polyurethane Tecoflex™ EM loaded with bismuth-based lipophilic nanoparticles (Tecoflex™ EMs-BisBAL NPs). The physicochemical and mechanical characteristics, along with the antitumor and bactericidal [...] Read more.
Electrospun membranes (EMs) have a wide range of applications, including use as local delivery systems. In this study, we manufactured a polyurethane Tecoflex™ EM loaded with bismuth-based lipophilic nanoparticles (Tecoflex™ EMs-BisBAL NPs). The physicochemical and mechanical characteristics, along with the antitumor and bactericidal effects, were evaluated using a breast cancer cell line and methicillin-susceptible and resistant Staphylococcus aureus (MRSA). Drug-free Tecoflex™ EMs and Tecoflex™ EMs-BisBAL NPs had similar fiber diameters of 4.65 ± 1.42 µm and 3.95 ± 1.32 µm, respectively. Drug-free Tecoflex™ EMs did not negatively impact a human fibroblast culture, indicating that the vehicle is biocompatible. Tecoflex™ EMs-BisBAL NPs increased 94% more in size than drug-free Tecoflex™ EMs, indicating that the BisBAL NPs enhanced hydration capacity. Tecoflex™ EMs-BisBAL NPs were highly bactericidal against both methicillin-susceptible S. aureus and MRSA clinical isolates, inhibiting their growth by 93.11% and 61.70%, respectively. Additionally, Tecoflex™ EMs-BisBAL NPs decreased the viability of MCF-7 tumor cells by 86% after 24 h exposure and 70.1% within 15 min. Regarding the mechanism of action of Tecoflex™ EMs-BisBAL NPs, it appears to disrupt the tumor cell membrane. In conclusion, Tecoflex™ EMs-BisBAL NPs constitute an innovative low-cost drug delivery system for human breast cancer and postoperative wound infections. Full article
(This article belongs to the Special Issue Active Biomedical Materials and Their Applications, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Characterization of BisBAL NPs by scanning electron microscopy (SEM). BisBAL NPs morphology, size, and distribution were obtained by SEM (SEM; Carl Zeiss Auriga FIB-SEM &amp; TEM, Oberkochen, Germany). The chemical composition and X-ray diffraction pattern corroborated bismuth (Bi) presence within the samples.</p>
Full article ">Figure 2
<p>Characterization of Tecoflex™ EMs-BisBAL NPs by SEM-EDX. (<b>A</b>) Physical appearance of drug-free and Tecoflex™ EMs-BisBAL NPs. (<b>B</b>,<b>C</b>) SEM revealed similar fiber size. Drug-free Tecoflex™ EM is white, whereas Tecoflex™ EMs-BisBAL NPs has a grey hue. (<b>D</b>) EDX spectra were similar except for the bismuth peaks.</p>
Full article ">Figure 3
<p>FTIR, Raman, water absorption, and mechanical characteristics of Tecoflex™ EMs–BisBAL NPs. (<b>A</b>) Raman spectra, (<b>B</b>) FTIR spectra, and (<b>C</b>) Swelling pattern of Tecoflex–EMs-BisBAL NPs and drug-free Tecoflex™ EMs. Bars indicate mean ± SD, n = 3. (<b>D</b>) The load–displacement curve of Tecoflex™ EMs BisBAL NPs and drug-free Tecoflex™ EM.</p>
Full article ">Figure 4
<p>Proliferation assay of drug-free Tecoflex™ EMs on HGFs. A HGF culture on drug-free Tecoflex™ EMs was analyzed after 24, 48, and 72 h post-incubation (37 °C; 5% CO<sub>2</sub>). Cells grown without EMs served as a growth control (CTRL). (<b>I</b>) Cells seeded on top of drug-free Tecoflex™ EMs in a 96-well plate. (<b>II</b>) HGF´s growth curves in time when exposed to drug-free Tecoflex™ EMs for 24, 48, and 72 h or not. Bars indicate mean ± SD, n = 3. At day 3, there was no statistically significant growth difference between HGFs cultured on drug-free Tecoflex™ EMs and controls. (<b>III</b>) HGFs culture on drug-free Tecoflex™ EMs were observed by fluorescent microscopy after SYTO<sup>TM</sup> 9 staining. (<b>IV</b>) Merging of SYTO<sup>TM</sup> 9 HGFs (fluorescence microscopy) and drug-free Tecoflex™ EMs fibers (clear field microscopy).</p>
Full article ">Figure 5
<p>MALDI-TOF mass spectra of <span class="html-italic">MRSA</span>-CI. Software, flexAnalysis (Bruker Daltonics): <span class="html-italic">MRSA</span> spectrum.</p>
Full article ">Figure 6
<p>Bactericidal activity of Tecoflex™ EMs-BisBAL NPs against methicillin-susceptible and resistant <span class="html-italic">S. aureus</span> (<span class="html-italic">MSSA</span>-ATCC and <span class="html-italic">MRSA</span>-CI, respectively). (<b>A</b>) Disk diffusion assay after 24 h exposure to Tecoflex™ EMs-BisBAL NPs, drug-free Tecoflex™ EM (negative control), 10 mM vancomycin (inhibition control), and 10 mM BisBAL NPs. (i) MSSA-ATCC strain and (ii) MRSA-CI. (<b>B</b>) Colony counting assay. Bacterial suspensions were serially diluted and exposed to the indicated drugs for 3 h. Next, the bacteria were plated, and the UFCs were counted after 24 h. Bactericidal activity was significantly increased with Tecoflex<sup>TM</sup> EMs-BisBAL NPs treatment compared with vancomycin for MRSA C.I. (* <span class="html-italic">p</span> &lt; 0.021). Bars indicate mean ± SD (n = 4); asterisks indicate statistical significance.</p>
Full article ">Figure 7
<p>Antitumor activity of Tecoflex™ EMs-BisBAL NPs on human breast cancer cells. (<b>A</b>) Presto Blue cell viability assay was used to measure the ability of Tecoflex™ EMs-BisBAL NPs to inhibit the proliferation of MCF-7 cells. Drug-free Tecoflex™ EMs were used as negative control and 1 mM doxorubicin (DOX) as growth inhibition control. After 24 h incubation (37 °C; 5% CO<sub>2</sub>), cell viability was measured and expressed as percentage of a non-exposed growth control (CTRL). (<b>B</b>) The efficiency of the drugs was verified by repeating the experiment with shorter exposure times (15, 30, 60, and 120 min). Antitumoral activity was significantly increased with Tecoflex<sup>TM</sup> EMs-BisBAL NPs treatment compared with growth control and drug-free Tecoflex™ EM (<span class="html-italic">p</span> &lt; 0.0001), except for doxorubicin group with a significance difference of <span class="html-italic">p</span> &lt; 0.01. Bars indicate mean ± SD (n = 3); asterisks indicate statistical significance.</p>
Full article ">Figure 8
<p>The effect of Tecoflex™ EMs-BisBAL NPs on MCF-7 viability and membrane permeability. MCF-7 cells were exposed for 15 min–24 h to Tecoflex™ EMs-BisBAL NPs and controls, before verifying cell viability and membrane permeability by calcein AM exposure according to the manufacturer´s instruction. Tumor cells grown in culture media without exposure to the drug were used as a growth control (CTRL), while 1 mM doxorubicin (DOX) served as a growth inhibition control.</p>
Full article ">
22 pages, 4192 KiB  
Review
Exosome-Laden Hydrogels as Promising Carriers for Oral and Bone Tissue Engineering: Insight into Cell-Free Drug Delivery
by Cassandra Villani, Prasathkumar Murugan and Anne George
Int. J. Mol. Sci. 2024, 25(20), 11092; https://doi.org/10.3390/ijms252011092 (registering DOI) - 15 Oct 2024
Viewed by 329
Abstract
Mineralization is a key biological process that is required for the development and repair of tissues such as teeth, bone and cartilage. Exosomes (Exo) are a subset of extracellular vesicles (~50–150 nm) that are secreted by cells and contain genetic material, proteins, lipids, [...] Read more.
Mineralization is a key biological process that is required for the development and repair of tissues such as teeth, bone and cartilage. Exosomes (Exo) are a subset of extracellular vesicles (~50–150 nm) that are secreted by cells and contain genetic material, proteins, lipids, nucleic acids, and other biological substances that have been extensively researched for bone and oral tissue regeneration. However, Exo-free biomaterials or exosome treatments exhibit poor bioavailability and lack controlled release mechanisms at the target site during tissue regeneration. By encapsulating the Exos into biomaterials like hydrogels, these disadvantages can be mitigated. Several tissue engineering approaches, such as those for wound healing processes in diabetes mellitus, treatment of osteoarthritis (OA) and cartilage degeneration, repair of intervertebral disc degeneration, and cardiovascular diseases, etc., have been exploited to deliver exosomes containing a variety of therapeutic and diagnostic cargos to target tissues. Despite the significant efficacy of Exo-laden hydrogels, their use in mineralized tissues, such as oral and bone tissue, is very sparse. This review aims to explore and summarize the literature related to the therapeutic potential of hydrogel-encapsulated exosomes for bone and oral tissue engineering and provides insight and practical procedures for the development of future clinical techniques. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic illustration of exosome-laden hydrogels for bone and oral tissue engineering.</p>
Full article ">Figure 2
<p>Drug delivery in tissue engineering applications for dental, oral, and craniofacial regeneration. In situ formation of injectable matrices or preshaped implants can be used to provide growth factors or other bioactive molecules for the regeneration of teeth, periodontal tissues, temporomandibular joints, cranial sutures, salivary glands and calvarial bone (Adapted from [<a href="#B31-ijms-25-11092" class="html-bibr">31</a>]).</p>
Full article ">Figure 3
<p>Clinical and therapeutic applications of oral tissue engineering in dentistry (Adapted from [<a href="#B28-ijms-25-11092" class="html-bibr">28</a>]).</p>
Full article ">Figure 4
<p>Applications of engineered hydrogels for oral tissue regeneration (Adapted from [<a href="#B42-ijms-25-11092" class="html-bibr">42</a>]).</p>
Full article ">Figure 5
<p>(<b>A</b>) Demonstrated use of secreted exosomes for dental tissue regeneration and as biomarkers for periodontitis and dental caries (Reprinted from [<a href="#B56-ijms-25-11092" class="html-bibr">56</a>] with permission from Elsevier). (<b>B</b>) The development of chitosan hydrogel loaded with exosomes derived from dental pulp stem cells to aid in healing periodontal tissues damaged by periodontitis (Reprinted from [<a href="#B71-ijms-25-11092" class="html-bibr">71</a>]).</p>
Full article ">Figure 6
<p>(<b>A</b>) Illustration of the bone, showing the cellular distribution and overall structure. Osteoprogenitors are abundant in the bone marrow and periosteum and play important roles in bone repair. In addition, a considerable degree of vascularization is seen in the periosteal and intramedullary canals of the bone (Adapted from [<a href="#B76-ijms-25-11092" class="html-bibr">76</a>]). (<b>B</b>) Steps for the implantation of biomaterial-loaded scaffolds for bone tissue engineering. Mesenchymal cells are isolated from the donor, cultured in vitro to differentiate into osteoblasts, and then loaded onto scaffolds that contain growth factors, polymers, biomaterials, nanoparticles, etc., prior to implantation. Following their implantation, the scaffolds could promote bone healing and regeneration (Adapted from [<a href="#B81-ijms-25-11092" class="html-bibr">81</a>]).</p>
Full article ">Figure 7
<p>Applications of hydrogels in bone tissue engineering (Adapted from [<a href="#B88-ijms-25-11092" class="html-bibr">88</a>]).</p>
Full article ">Figure 8
<p>Illustration of cell-derived exosomes with cargo during bone and cartilage regeneration (Adapted from [<a href="#B107-ijms-25-11092" class="html-bibr">107</a>]).</p>
Full article ">Figure 9
<p>(<b>A</b>) Schematic illustration of uMSCEXO isolation for HA-Gel embedding and nHP scaffold printing to heal the critical-size cranial defect in rats by promoting angiogenesis (Reprinted with permission from [<a href="#B117-ijms-25-11092" class="html-bibr">117</a>]). (<b>B</b>). Schematic illustration of the isolation and characterization of hucMSC-derived exosomes and synthesis of CHA/SF/GCS/DF-PEG hydrogel with exosomes for testing in Sprague–Dawley rats with an induced femoral condyle defect (Reprinted from [<a href="#B119-ijms-25-11092" class="html-bibr">119</a>]).</p>
Full article ">Figure 10
<p>A rationale for the design of exosome-laden hydrogels. (<b>A</b>) Fabrication of GelMA with subsequent hPDLF-Exo embedding and hydrogelation via photo-crosslinking. (<b>B</b>) Application of GelMA (right) and GelMA/hPDLFs-Exo (left) hydrogels into calvarial defects in a rat model (Reprinted from [<a href="#B123-ijms-25-11092" class="html-bibr">123</a>] with permission from Elsevier). (<b>C</b>) Schematic illustration of photoinduced imine crosslinking (PIC) hydrogel integrated with human induced pluripotent stem cells (hiPSC) derived exosomes for cartilage regeneration (Adapted from [<a href="#B126-ijms-25-11092" class="html-bibr">126</a>]).</p>
Full article ">
18 pages, 914 KiB  
Review
Exploring the Therapeutic Potential of Jujube (Ziziphus jujuba Mill.) Extracts in Cosmetics: A Review of Bioactive Properties for Skin and Hair Wellness
by Daniela Batovska, Anelia Gerasimova and Krastena Nikolova
Cosmetics 2024, 11(5), 181; https://doi.org/10.3390/cosmetics11050181 (registering DOI) - 15 Oct 2024
Viewed by 487
Abstract
Jujube (Ziziphus jujuba Mill.), native to Southern Asia, stands out for its significant nutritional and therapeutic properties. Its adaptability and resilience have enabled its global cultivation, highlighting the necessity for comprehensive scientific research to fully harness its potential. Rich in bioactive compounds [...] Read more.
Jujube (Ziziphus jujuba Mill.), native to Southern Asia, stands out for its significant nutritional and therapeutic properties. Its adaptability and resilience have enabled its global cultivation, highlighting the necessity for comprehensive scientific research to fully harness its potential. Rich in bioactive compounds like flavonoids, polyphenols, vitamin C, polysaccharides, tannins, and saponins, jujube extracts exhibit notable antioxidant, anti-inflammatory, antimicrobial, and wound healing properties. These qualities have made jujube a popular ingredient in various skin and hair care formulations. The versatility of jujube extracts, along with their synergy with other herbal active ingredients, enables the development of targeted personal care solutions. These solutions address a range of concerns, including anti-aging, UV protection, brightening, moisturizing, and calming effects, as well as promoting hair health. Despite its potential, research on the cosmetic applications of Z. jujuba is still in its early stages, with only one clinical trial to date focusing on its skin-brightening effects. This review aims to consolidate the current and emerging research on the applications of jujube in conventional and medical cosmetics, highlighting its potential in enhancing skin and hair wellness. By providing a comprehensive overview, it seeks to pave the way for further studies and innovations in utilizing jujube for personal care. Full article
Show Figures

Figure 1

Figure 1
<p>Future directions in the utilization of the therapeutic potential of jujube in cosmetics.</p>
Full article ">
18 pages, 7715 KiB  
Article
Pristine Photopolymerizable Gelatin Hydrogels: A Low-Cost and Easily Modifiable Platform for Biomedical Applications
by Maria Pérez-Araluce, Alessandro Cianciosi, Olalla Iglesias-García, Tomasz Jüngst, Carmen Sanmartín, Íñigo Navarro-Blasco, Felipe Prósper, Daniel Plano and Manuel M. Mazo
Antioxidants 2024, 13(10), 1238; https://doi.org/10.3390/antiox13101238 (registering DOI) - 15 Oct 2024
Viewed by 323
Abstract
The study addresses the challenge of temperature sensitivity in pristine gelatin hydrogels, widely used in biomedical applications due to their biocompatibility, low cost, and cell adhesion properties. Traditional gelatin hydrogels dissolve at physiological temperatures, limiting their utility. Here, we introduce a novel method [...] Read more.
The study addresses the challenge of temperature sensitivity in pristine gelatin hydrogels, widely used in biomedical applications due to their biocompatibility, low cost, and cell adhesion properties. Traditional gelatin hydrogels dissolve at physiological temperatures, limiting their utility. Here, we introduce a novel method for creating stable hydrogels at 37 °C using pristine gelatin through photopolymerization without requiring chemical modifications. This approach enhances consistency and simplifies production and functionalization of the gelatin with bioactive molecules. The stabilization mechanism involves the partial retention of the triple-helix structure of gelatin below 25 °C, which provides specific crosslinking sites. Upon activation by visible light, ruthenium (Ru) acts as a photosensitizer that generates sulphate radicals from sodium persulphate (SPS), inducing covalent bonding between tyrosine residues and “locking” the triple-helix conformation. The primary focus of this work is the characterization of the mechanical properties, swelling ratio, and biocompatibility of the photopolymerized gelatin hydrogels. Notably, these hydrogels supported better cell viability and elongation in normal human dermal fibroblasts (NHDFs) compared to GelMA, and similar performance was observed for human pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). As a proof of concept for functionalization, gelatin was modified with selenous acid (GelSe), which demonstrated antioxidant and antimicrobial capacities, particularly against E. coli and S. aureus. These results suggest that pristine gelatin hydrogels, enhanced through this new photopolymerization method and functionalized with bioactive molecules, hold potential for advancing regenerative medicine and tissue engineering by providing robust, biocompatible scaffolds for cell culture and therapeutic applications. Full article
(This article belongs to the Special Issue Applications and Health Benefits of Novel Antioxidant Biomaterials)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Hydrogel formation. Schematic representation of the polymerization process of pristine gelatin.</p>
Full article ">Figure 2
<p>Gelatin functionalization with selenium (GelSe). (<b>A</b>) Synthesis reaction of GelSe. (<b>B</b>) Schematic representation of GelSe hydrogel formation. (<b>C</b>) Schematic representation of the obtention of gelatin with different degree of functionalization (DoF) by mixing GelSe/GelSe-H (high DoF) with pristine gelatin in proportions 1:1 and 1:2 to obtain GelSe-M (medium DoF) and GelSe-L (low DoF), respectively.</p>
Full article ">Figure 3
<p>Rheological and photorheological tests (n = 3, 10 rad/s oscillation frequency, 10% shear strain) for the analysis of the viscosity and the viscoelastic properties of the pristine gelatin and polymerize pristine gelatin. (<b>A</b>) Viscosity profile of pristine gelatin at different concentrations (10, 7.5 and 5% <span class="html-italic">w</span>/<span class="html-italic">v</span>). (<b>B</b>) Temperature sweep of pristine gelatin. (<b>C</b>) Time sweep of gelatin at 37 °C (light activated at 20 s, 35 s exposure time, 7.5 cm light probe-to-sample distance). (<b>D</b>) Time sweep of gelatin previously incubated for 5 min at 21 °C (light activated at 20 s, 35 s exposure time, 7.5 cm light probe-to-sample distance). (<b>E</b>) Amplitude sweep of pristine gelatin hydrogel. (<b>F</b>) Frequency sweep of pristine gelatine hydrogel.</p>
Full article ">Figure 4
<p>Autofluorescence of dityrosine groups in response to UV light exposure. (<b>A</b>) Light-activated pristine gelatin hydrogels. (<b>B</b>) Non-activated pristine gelatin hydrogels. (<b>C</b>) Ru/SPS 1/10 mM solution in PBS. (<b>D</b>) Pristine gelatin 10% <span class="html-italic">w</span>/<span class="html-italic">v</span> in PBS.</p>
Full article ">Figure 5
<p>Swelling ratio. (<b>A</b>) Representation of the hydrogel diameter in cm after incubation in PBS at 37 °C over 30 days (N = 12). (<b>B</b>) Images showing the evolution of the hydrogel incubated in PBS at 37 °C over 30 days.</p>
Full article ">Figure 6
<p>Material addition to cell culture. (<b>A</b>) Alamar Blue assay of pristine gelatin and GelMA 10% <span class="html-italic">w</span>/<span class="html-italic">v</span> addition to NHDFs cultured in a 96-well plate. (<b>B</b>) Alamar Blue assay of pristine gelatin and GelMA 10% <span class="html-italic">w</span>/<span class="html-italic">v</span> addition to hiPSC-CMs cultured in a 96-well plate. (N = 3, unpaired <span class="html-italic">t</span>-test, ** <span class="html-italic">p</span> &lt; 0.005, ns: no significant differences).</p>
Full article ">Figure 7
<p>Cell encapsulation. (<b>A</b>) Alamar Blue assay of NHDFs encapsulated within pristine gelatin and GelMA 10% <span class="html-italic">w</span>/<span class="html-italic">v</span>. (<b>B</b>) Alamar Blue assay of hiPSC-CMs encapsulated within pristine gelatin and GelMA 10% <span class="html-italic">w</span>/<span class="html-italic">v</span>. (N = 3, unpaired <span class="html-italic">t</span>-test, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.005, ns = no significative differences). (<b>C</b>) Fluorescence images of Live/Dead<sup>®</sup> assay of NHDFs encapsulated within pristine gelatin and GelMA 10% <span class="html-italic">w</span>/<span class="html-italic">v</span>. (<b>D</b>) Fluorescence images of Live/Dead assay of hiPSC-CMs encapsulated within pristine gelatin and GelMA 10% <span class="html-italic">w</span>/<span class="html-italic">v</span>. Live cells produced green fluorescence and dead cells showed red fluorescence.</p>
Full article ">Figure 8
<p>(<b>A</b>) <sup>77</sup><span class="html-italic">Se</span>-NMR of GelSe. (<b>B</b>) <sup>1</sup><span class="html-italic">H</span>-NMR of pristine gelatin (blue) and GelSe (red).</p>
Full article ">Figure 9
<p>Antioxidant properties of GelSe. DPPH analysis of GelSe-H. Results were calculated relative to a positive control (ascorbic acid 2 mg/mL). The “Ascorbic acid” result is the antioxidant capacity of ascorbic acid at 0.023 mg/mL, the equivalent concentration of selenium found in GelSe-H. (N = 3, unpaired <span class="html-italic">t</span>-test, *** <span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 10
<p>Antibacterial properties of GelSe against <span class="html-italic">Escherichia coli</span> (<span class="html-italic">E. coli</span>) and <span class="html-italic">Staphylococcus aureus</span> (<span class="html-italic">S. aureus</span>). (<b>A</b>) Antibacterial properties of GelSe/GelSe-H. Agar plate culture of a sample from a 96-well plate containing 1 million bacteria of <span class="html-italic">E. coli</span> (left) and <span class="html-italic">S. aureus</span> (right), treated with five different concentrations of GelSe (GelSe-H.1 (13%), H.2 (10%), H.3.3 (6.67%), H.4 (5%), and H.5 (3.33% <span class="html-italic">w</span>/<span class="html-italic">v</span>)). (<b>B</b>) Antibacterial properties of GelSe-M.1 to GelSe-M.5 with <span class="html-italic">E. coli</span> (left) and <span class="html-italic">S. aureus</span> (right). (<b>C</b>) Antibacterial properties of GelSe-L.1 to GelSe-L.5 with <span class="html-italic">E. coli</span> (left) and <span class="html-italic">S. aureus</span> (right), including a control for each bacterial strain using pristine gelatin.</p>
Full article ">Figure 11
<p>Biocompatibility properties of different concentrations of GelSe-H and GelSe-M added to NHDFs. (<b>A</b>) Alamar blue assay (N = 3, unpaired <span class="html-italic">t</span>-test, *** <span class="html-italic">p</span> &lt; 0.001, ns = no significative differences). (<b>B</b>) Fluorescence images of Live/Dead<sup>®</sup> assay. Live cells produced green fluorescence and dead cells showed red fluorescence. Scale bars are 100 µm.</p>
Full article ">Figure 12
<p>Comparative table of GelSe-H and GelSe-M showing their antibacterial and biocompatibility properties. GelSe-M.3 is proposed as the best candidate, as it demonstrates good cell viability and antibacterial properties. X: not bactericidal/not biocompatible; ✓: bactericidal/biocompatible.</p>
Full article ">
13 pages, 1154 KiB  
Article
Body Weight’s Role in Infective Endocarditis Surgery
by Ahmed Elderia, Gerold Woll, Anna-Maria Wallau, Walid Bennour, Stephen Gerfer, Ilija Djordjevic, Thorsten Wahlers and Carolyn Weber
J. Cardiovasc. Dev. Dis. 2024, 11(10), 327; https://doi.org/10.3390/jcdd11100327 (registering DOI) - 15 Oct 2024
Viewed by 257
Abstract
Objective: to investigate how body mass index (BMI) affects the outcome in patients treated surgically for infective endocarditis (IE). Methods: This is a single-center observational analysis of consecutive patients treated surgically for IE. We divided the cohort into six groups, according to the [...] Read more.
Objective: to investigate how body mass index (BMI) affects the outcome in patients treated surgically for infective endocarditis (IE). Methods: This is a single-center observational analysis of consecutive patients treated surgically for IE. We divided the cohort into six groups, according to the WHO classification of BMI, and performed subsequent outcome analysis. Results: The patient population consisted of 17 (2.6%) underweight, 249 (38.3%) normal weight, 252 (38.8%) overweight, 83 (12.8%) class I obese, 28 (4.3%) class II obese, and 21 (3.8%) class III, or morbidly obese, patients. The median age of the entire cohort was 64.5 [52.5–73.6] years. While only 168 (25.9%) patients were female, women significantly more often exhibited extremes in regards to BMI, including underweight (47.1%) and morbid obesity (52.4%), p = 0.026. Class II and III obese patients displayed more postoperative acute kidney injury (47.9%), p = 0.003, more sternal wound infection (12.9%), p < 0.001, worse 30-day survival (20.4%), p = 0.031, and worse long-term survival, p = 0.026, compared to the results for the other groups. However, the multivariable analysis did not identify obesity as an independent risk factor for 30-day mortality, with an odds ratio of 1.257 [0.613–2.579], p = 0.533. Rather, age > 60, reduced LVEF < 30%, staphylococcal infection, and prosthetic valve endocarditis correlated with mortality. While BMI showed poor discrimination in predicting 30-day mortality on the ROC curve (AUC = 0.609), it showed a fair degree of discrimination in predicting sternal wound infection (AUC = 0.723). Conclusions: Obesity was associated with increased comorbidities, complications, and higher postoperative mortality in IE patients, but it is not an independent mortality risk factor. While BMI is a poor predictor of death, it is a good predictor of sternal wound infections. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Kaplan–Meier survival estimation, according to BMI classes.</p>
Full article ">Figure 2
<p>Survival estimation for the combined groups.</p>
Full article ">Figure 3
<p>ROC curves for 30-day mortality (<b>A</b>) and for sternal wound infection (<b>B</b>).</p>
Full article ">
10 pages, 9332 KiB  
Article
Vascularised and Non-Vascularised Adipofascial Flap Applications in Tissue Trauma with Tendon Injury, Flap Viability and Tendon Healing a Hystological and Scintigraphical Rat Model Study
by Mehmet Yucens, Ahmet Nadir Aydemir, Tarık Sengoz, Gulcin Abban Mete, Nusret Ök, Mehmet Rauf Koç and Ahmet Fahir Demirkan
Medicina 2024, 60(10), 1689; https://doi.org/10.3390/medicina60101689 (registering DOI) - 15 Oct 2024
Viewed by 405
Abstract
Background and Objectives: Complex wounds in the hand and distal lower extremities pose challenges in reconstructive surgery, often involving critical structures like tendons. Tendon injuries, prevalent in such wounds, necessitate optimal repair methods for functional recovery. This study investigates the impact of [...] Read more.
Background and Objectives: Complex wounds in the hand and distal lower extremities pose challenges in reconstructive surgery, often involving critical structures like tendons. Tendon injuries, prevalent in such wounds, necessitate optimal repair methods for functional recovery. This study investigates the impact of vascularised and nonvascularised adipofascial tissue on tendon repair, focusing on early healing stages, mobilisation, and scintigraphic evaluation of flap vascularity. Materials and Methods: Wistar Albino rats were divided into groups undergoing primary tendon repair, vascularised adipofascial flap application, or nonvascularised flap application. Scintigraphic evaluation and histopathological assessment were performed to analyse healing processes. Results: Pedicle-free flaps support healing in tendon injuries without negatively affecting medium-term outcomes. Vascularised flaps exhibit faster healing. The scintigraphic analysis showed that the static measurements of the late phase were statistically significantly higher in the group with the non-vascularised adipofascial flap (p = 0.038). The mean perfusion reserve was higher in the vascularised pedicled adipofascial flap group than the non-vascularised adipofascial flap group. Scintigraphic analysis highlights the viability of pedicle-free flaps. Conclusions: Pedicle-free adipofascial flaps support the healing of the tendon without complicating the results, while vascularised flaps show accelerated healing. These findings provide valuable insights into optimising tendon repair strategies using adipofascial flaps, with implications for enhancing functional recovery in complex wounds. Full article
(This article belongs to the Section Orthopedics)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Depilation and sterilisation with povidone iodine. (<b>B</b>) Precise incision the gastrocnemius fascia was released from proximal to distal.</p>
Full article ">Figure 2
<p>(<b>A</b>) The arterioles of the gastrocnemius fascia. (<b>B</b>) The Achilles tendon was cut transversely with a scalpel. (<b>C</b>) The Achilles tendon was repaired using a modified Kessler technique.</p>
Full article ">Figure 3
<p>(<b>A</b>,<b>B</b>) Vascularised pedicle flap suturation and coverage. (<b>C</b>) Non-vascularised pedicle flap suturation and coverage.</p>
Full article ">Figure 4
<p>Tc-99m-methoxy isobutyl isonitrile (MIBI) was injected into the tail vein under a camera.</p>
Full article ">Figure 5
<p>Scintigraphic images.</p>
Full article ">Figure 6
<p>Histological score of groups.</p>
Full article ">
11 pages, 373 KiB  
Article
Temporal Variability in the Incidence and Risk Factors for Pharyngocutaneous Fistula Development after Total Laryngectomy
by Robert Šifrer, Maja Dolenc, Sara Bitenc Zore, Simon Fugina, Luka Jesenko and Primož Strojan
Cancers 2024, 16(20), 3486; https://doi.org/10.3390/cancers16203486 (registering DOI) - 15 Oct 2024
Viewed by 219
Abstract
Background: This study aimed to analyse the variability in the incidence of the pharyngocutaneous fistula (PCF), the most common complication following a total laryngectomy (TLE), and to identify the underlying causes for fluctuations in incidence rates. Methods: In the retrospective study, the annual [...] Read more.
Background: This study aimed to analyse the variability in the incidence of the pharyngocutaneous fistula (PCF), the most common complication following a total laryngectomy (TLE), and to identify the underlying causes for fluctuations in incidence rates. Methods: In the retrospective study, the annual PCF incidence data and comprehensive clinicopathologic data from 540 patients who underwent TLE between January 2004 and December 2022 were reviewed. Distinct peri ods of both high and low PCF incidence were identified. Within these periods, patients were categorized into groups with PCF (study groups) and without it (control groups). These groups were statistically compared based on potential risk factors for PCF development. The high-incidence periods were specially analysed for recurring risk factors and the corresponding corrective measures were reviewed. Results: The analysis revealed four high-incidence periods with an overall PCF incidence of 37.61%, along with three low-incidence periods in between with an overall incidence of 19.38%. Surgical wound infection (SWI) and a history of head and neck cancer alongside their related treatments were repeatedly identified as independent risk factors during high-incidence periods, with SWI being the most consistent predictor of PCF development. Conclusions: Continuous monitoring of PCF incidence is crucial, as it allows for the identification of emerging risk factors and the immediate implementation of corrective measures to mitigate these newly identified risk factors. Full article
(This article belongs to the Special Issue Emerging Technologies in Head and Neck Cancer Surgery)
Show Figures

Figure 1

Figure 1
<p>The annual incidences in relation to the year of TLE. Periods of high incidences (H1–H4) are marked in red and periods of low incidences (L1–L3) are marked in green.</p>
Full article ">
19 pages, 3675 KiB  
Article
Exploring the Role of miR-132 in Rat Bladders and Human Urothelial Cells during Wound Healing
by Clara I. Chamorro and Magdalena Fossum
Int. J. Mol. Sci. 2024, 25(20), 11039; https://doi.org/10.3390/ijms252011039 - 14 Oct 2024
Viewed by 310
Abstract
Urinary bladder wound healing shares many features with skin healing, involving several molecular players, including microRNAs (miRs). This study investigated the role of miR-132 in urothelial cells. We analyzed miR-132 expression in rat bladder using in situ hybridization and conducted gain and loss [...] Read more.
Urinary bladder wound healing shares many features with skin healing, involving several molecular players, including microRNAs (miRs). This study investigated the role of miR-132 in urothelial cells. We analyzed miR-132 expression in rat bladder using in situ hybridization and conducted gain and loss of miR-132 function assays in primary human urothelial cells (HUCs). These assays included cell proliferation and migration studies. To explore the regulation of miR-132 expression, cells were treated with wound-healing-related factors such as interleukin 6 (IL-6), interleukin 10 (IL-10), and transforming growth factor beta-1 (TGF-β1). Predictive bioinformatics and a literature review identified potential miR-132 targets, which were validated through real-time polymerase chain reaction (RT-PCR) and Western blot analysis. miR-132 was found to promote cellular proliferation and migration during the early stages of urothelial wound repair. Its expression was modulated by key cytokines such as IL-6, IL-10, and TGF-β1. miR-132 played a crucial role in urothelial wound healing by enhancing cell proliferation and migration, regulated by cytokines, suggesting its action within a complex regulatory network. These findings highlight the therapeutic potential of targeting miR-132 in bladder injury repair, offering new insights into bladder repair mechanisms. Full article
(This article belongs to the Special Issue Non-coding RNA in Physiology and Pathophysiology)
Show Figures

Figure 1

Figure 1
<p>Expression of miR-132 during in vivo rodent bladder wound healing. (<b>a</b>) RNA from rodent urinary bladder samples (n = 4 rats, each time point) was analyzed using real-time polymerase chain reaction (RT-PCR) for miR-132 expression. (<b>b</b>) Representative histological sections showing proliferation (ki67) and inflammation (CD68) markers during the first and second weeks of healing. The values are expressed as a fold change relative to non-wounded control bladders. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 2
<p>MiR-132 expression was mainly found in the mucosa during the first week of healing. In situ hybridization in non-wounded (control) and wounded bladders at (<b>a</b>,<b>b</b>) 6 h and (<b>e</b>–<b>n</b>) 2–28 days post wounding. (<b>a</b>,<b>c</b>,<b>e</b>,<b>g</b>,<b>i</b>,<b>k</b>,<b>m</b>) Digoxigenin (DIG)-labeled miRCURY LNA scramble probes (scr) or (<b>b</b>,<b>d</b>,<b>f</b>,<b>h</b>,<b>j</b>,<b>l</b>,<b>n</b>) probes specifically designed for miR-132 were used. MiR-132 (blue-purple color) was detected mainly in the urothelial cell layers, with some positive cells in the submucosa and around the suture areas, where persistent inflammation reaction was observed (dark triangles). Two out of four animals per time point and condition were analyzed.</p>
Full article ">Figure 3
<p>Human urothelial cells (HUCs) upregulated miR-132 expression after in vitro scratch wounding. (<b>a</b>) Representative HUC pictures illustrating the progression of an in vitro scratch wound. Green dotted lines represent original wound. Yellow dotted lines represent the area where the cells had migrated. (<b>b</b>) RT-PCR analysis of the expression of miR-132 in HUC upon wounding (n = 3). * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 4
<p>Wound healing-related signaling molecules that modulated miR-132 expression. Primary HUCs were treated with (<b>a</b>) interleukin 6 (IL-6), (<b>b</b>) interleukin 10 (IL-10), and (<b>c</b>) transforming growth factor beta-1 (TGF-β1) (n = 4). The expression of miR-132 was evaluated using digital PCR. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 5
<p>Gain in miR-132 expression induced an increase in cell proliferation. Primary HUCs transfected with transfection reagent alone (mock), with different specific RNA molecules designed to (<b>a</b>,<b>b</b>) mimic or (<b>c</b>,<b>d</b>) inhibit endogenous miR-132 expression and their respective controls (<b>c</b>,<b>d</b>). A total of 10000 cells/well were transfected with 5 nM mimic or 50 nM inhibitor and their respective controls. The total number of cells were estimated after 2 and 4 days in culture (ns = not significant; * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001, n = 3).</p>
Full article ">Figure 6
<p>Gain in miR-132 expression accelerated in vitro wound healing. Gain and loss of function experiments using mimic or inhibitor molecules for miR-132 and respective controls. (<b>a</b>) Representative pictures showing the scratch area at time 0 and 24 h post wounding. Green lines marking the initial wound edges and yellow lines marking the wound edges 24 h later (<b>b</b>) Graph representing the average percentage of wound confluency and standard deviations over time in each experimental condition, performed in 6 replicates each. (<b>c</b>,<b>d</b>) Graph showing the percentage of wound confluence after different treatments 12 h after wounding (ns = not significant; * <span class="html-italic">p</span> &lt; 0.05. Representative data from one of a total three experiments are presented.</p>
Full article ">Figure 7
<p>MiR-132 modulated the mRNA expression of RAS p21 protein activator 1 (RASA1), Phosphatase and tensin homolog (PTEN), and Mitogen-activated protein kinase (MAPK). Quantitative RT-PCR analysis of the mRNA expression of HUCs upon transfection with the indicated concentrations of (<b>a</b>,<b>c</b>,<b>e</b>) mimic “M” and its corresponding control “MC” and (<b>b</b>,<b>d</b>,<b>f</b>) inhibitor “I” and its corresponding control “IC”. Graphs show average gene expression. (ns = not significant; * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 8
<p>Analysis of <span class="html-italic">RASA1</span>, <span class="html-italic">PTEN</span>, and <span class="html-italic">MAPK</span> protein expression in human primary urothelial cells. Representative image showing one of a total of two performed experiments analyzing protein expression with Western blot after transfection with transfection reagent alone (mock) or with specific double- and single-stranded RNA molecules designed to mimic “M” (<b>a</b>,<b>c</b>,<b>e</b>,<b>g</b>) or inhibit “I” (<b>b</b>,<b>d</b>,<b>f</b>,<b>h</b>) endogenous miR-132 and corresponding controls for mimic “MC” and inhibitor. L denotes protein padder sample. Lower bars represent normalized values to the housekeeping protein tubulin (one of the two experiments is represented).</p>
Full article ">Figure 9
<p>Simplified model of miR-132 in bladder injury repair. This figure illustrates the role of miR-132 in urothelial cells following urinary bladder injury. Upon injury, a cascade of molecular signals and cellular responses is triggered. An increase in inflammatory cytokines (pink), such as IL-6, IL-10, and TGF-β1, act upon the urothelium. This leads to the upregulation of miR-132. MiR-132 targets specific genes such as RASA1, PTEN, and MAPK (light-green box), which are crucial for cellular processes during repair. The downregulation of these target genes by miR-132 enhanced cell proliferation and migration (light-yellow box) and could thereby contribute to the repair mechanisms following bladder injury. The mechanism by which this genes mediate miR-132 effects need to be further explored (denoted by the question mark).</p>
Full article ">
11 pages, 3689 KiB  
Article
Isoorientin Improves Excisional Skin Wound Healing in Mice
by Aline B. Hora, Laiza S. Biano, Ana Carla S. Nascimento, Zaine T. Camargo, Greice I. Heiden, Ricardo L. C. Albulquerque-Júnior, Renata Grespan, Jessica M. D. A. Aragão and Enilton A. Camargo
Pharmaceuticals 2024, 17(10), 1368; https://doi.org/10.3390/ph17101368 - 14 Oct 2024
Viewed by 274
Abstract
Background/Objectives: Wound healing relies on a coordinated process with the participation of different mediators. Natural products are a source of active compounds with healing potential. Isoorientin is a natural flavone recognized as having several pharmacological properties, such as anti-inflammatory effects, making it [...] Read more.
Background/Objectives: Wound healing relies on a coordinated process with the participation of different mediators. Natural products are a source of active compounds with healing potential. Isoorientin is a natural flavone recognized as having several pharmacological properties, such as anti-inflammatory effects, making it a potential treatment for wounds. We investigated the effect of isoorientin on the healing of excisional skin wounds. Methods: Male Swiss mice were subjected to the induction of excisional skin wounds (6 mm diameter) and treated with a vehicle (2% dimethyl sulfoxide in propylene glycol) or 2.5% isoorientin applied topically once a day for 14 days. The wound area was measured on days 0, 3, 7, and 14. Histopathological analyses were performed on the cicatricial tissue after 14 days. The myeloperoxidase activity and the interleukin-1β, tumoral necrosis factor (TNF)-α, and interleukin-6 concentrations were determined on the third day. Results: We observed that 3 days after the topical application of isoorientin, the lesion area was significantly smaller when compared to those of the vehicle (p < 0.01) and control (p < 0.05) groups. No difference was observed after 7 and 14 days of induction. Despite this, on day 14, histological analysis of cicatricial tissue from the animals treated with isoorientin showed reduced epidermal thickness (p < 0.001) and increased collagen deposition (p < 0.001). These effects were accompanied by decreased myeloperoxidase activity and interleukin-1β concentration on the third day of induction, without alteration in TNF-α and interleukin-6. Conclusions: The treatment with isoorientin promoted better tissue repair in excisional wounds in mice, which may be linked to the modulation of the early inflammatory response. Full article
(This article belongs to the Special Issue Pharmacological Activities of Flavonoids and Their Analogues 2024)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The effect of isoorientin on the skin wound area at different time points. Mice were divided into control (no treatment), vehicle (2% dimethyl sulfoxide (DMSO) in propylene glycol), and 2.5% isoorientin (2.5% Iso) groups. The area of each skin lesion was measured at days 0, 3, 7, and 14 after induction, according to the experimental design (<b>A</b>). Representative images of the skin lesions of the groups at different time points are shown (<b>B</b>). The area of the skin lesions (<b>C</b>) is expressed as mean ± SD (n = 10/group at D0, 3, and 7, and n = 6/group at D14). Two-way analysis of variance (ANOVA) and the Bonferroni post hoc test were used. * <span class="html-italic">p</span> &lt; 0.05 or ** <span class="html-italic">p</span> &lt; 0.01 compared to the control or vehicle group, as indicated. Created in BioRender.com.</p>
Full article ">Figure 2
<p>Representative images of the wound tissues 14 days after induction, and quantification of the epidermal thickness. Histological sections stained with hematoxylin and eosin represent each experimental group’s epidermis and papillary/reticular dermis. Panoramic views of the groups—control (<b>A</b>), vehicle (<b>D</b>), 2.5% Iso (<b>G</b>), and healthy skin (<b>J</b>)—show the measurement of the granulation reaction depth (dotted lines with double arrows), epidermal acanthosis (ac), and residual granulation reaction (rgr) in the lamina propria (100×). Details of the granulation reaction and the deeper dermal portion in the control (<b>B</b>,<b>C</b>), vehicle (<b>E</b>,<b>F</b>), 2.5% Iso (<b>H</b>,<b>I</b>), and healthy skin (<b>K</b>,<b>L</b>) groups (400×) are shown. A violin plot shows the measurement of the mean epidermal thickness in the experimental groups (<b>M</b>), n = 6 animals with 6–8 measurements each. The Kruskal–Wallis and Dunn’s post hoc tests were used. *** <span class="html-italic">p</span> &lt; 0.001 and <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared to the control or vehicle groups.</p>
Full article ">Figure 3
<p>Representative images of Masson’s trichrome staining, and quantification of collagen deposition in the wound tissues 14 days after induction. Histological sections stained with Masson’s trichrome represent each experimental group’s papillary/reticular dermis area. Panoramic views of the control (<b>A</b>), vehicle (<b>B</b>), 2.5% Iso (<b>C</b>), and healthy tissue (<b>D</b>) groups (100×) are shown, along with the histological appearances of collagen fibers in the experimental groups and normal skin (<b>E</b>–<b>H</b>) (400×). The violin plot demonstrates the dermal collagen optical density (DCOD) determination in the experimental groups (<b>I</b>), n = 6 animals with 7–10 measurements each. Data are expressed as the median and minimum to maximum. Kruskal–Wallis and Dunn’s post hoc tests were used. *** <span class="html-italic">p</span> &lt; 0.001 and <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared to the control or vehicle groups.</p>
Full article ">Figure 4
<p>The effect of isoorientin on the myeloperoxidase activity and pro-inflammatory cytokine production in the wound tissues 3 days after induction. Mice were treated daily according to their respective groups: control (no treatment), vehicle (2% DMSO in propylene glycol), or Iso (2.5% Isoorientin). The wounds were analyzed on the third day to measure MPO activity (<b>A</b>) and the concentrations of IL-1β (<b>B</b>), TNF-α (<b>C</b>), and IL-6 (<b>D</b>). Data are expressed as mean ± SD (n = 5). Two-way ANOVA and the Bonferroni post hoc test were used. * <span class="html-italic">p</span> &lt; 0.05 and *** <span class="html-italic">p</span> &lt; 0.0001, respectively, compared to the vehicle group.</p>
Full article ">
18 pages, 20751 KiB  
Article
Insights into the Various Cellular Antimicrobial Responses, Biocompatibility, Osteogenesis, Wound Healing, and Angiogenesis of Copper-Doped Nano-Hydroxyapatite Composite Calcium Phosphate Bone Cement In Vitro
by Ssu-Meng Huang, Wen-Cheng Chen, Shih-Ming Liu, Chia-Ling Ko, Jian-Chih Chen and Chi-Jen Shih
J. Compos. Sci. 2024, 8(10), 424; https://doi.org/10.3390/jcs8100424 - 14 Oct 2024
Viewed by 348
Abstract
Calcium phosphate bone cement (CPC) is a popular material for bone remodeling, and nanohydroxyapatite (nHA) represents a breakthrough that has a wide range of clinical applications. During the early stages of bone repair, antibacterial and angiogenesis effects are essential to remodel new bone [...] Read more.
Calcium phosphate bone cement (CPC) is a popular material for bone remodeling, and nanohydroxyapatite (nHA) represents a breakthrough that has a wide range of clinical applications. During the early stages of bone repair, antibacterial and angiogenesis effects are essential to remodel new bone tissues. In this study, an antibacterial effect was achieved by incorporating Cu2+-doped nano-hydroxyapatite (Cu–nHA) synthesized through hydrothermal methods into CPC, and the impact of various amounts of Cu–nHA addition on the antibacterial and mechanical properties of CPC hybridization was evaluated. Moreover, the effects of Cu–nHA/CPC composites on the proliferation and mineralization of mouse progenitor osteoblastic cells (D1 cells) were characterized; the cell migration and angiogenesis ability of vascular endothelial cells (HUVECs) were also studied. Results indicated that incorporating 5 wt.% and 10 wt.% Cu–nHA into CPC led to a practical short-term antibacterial effect on S. aureus but not on E. coli. These Cu–nHA/CPC slurries remained injectable, anti-disintegrative, and non-toxic. Furthermore, compared with pure CPC, these Cu–nHA/CPC slurries demonstrated positive effects on D1 cells, resulting in better proliferation and mineralization. In addition, these Cu–nHA/CPC slurries were more effective in promoting the migration and angiogenesis of HUVECs. These findings indicate that 10 wt.% Cu–nHA/CPC has great application potential in bone regeneration. Full article
(This article belongs to the Section Biocomposites)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>FTIR spectra (<b>a</b>) and XRD patterns (<b>b</b>) of CPC-only and Cu–nHA nanoparticle composite CPC, added with 5 wt.% and 10 wt.% Cu–nHA nanoparticles, respectively, were obtained after 1 day of further reaction in Tris buffer solution.</p>
Full article ">Figure 2
<p>Antibacterial activities of CPC only, 5 wt.% Cu–nHA/CPC, and 10 wt.% Cu–nHA against (<b>a</b>) <span class="html-italic">S. aureus</span> and (<b>b</b>) <span class="html-italic">E. coli</span> cultured for 4 days. * Indicates that the groups were significantly different (<span class="html-italic">p</span> &lt; 0.05) based on one-way ANOVA (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 2 Cont.
<p>Antibacterial activities of CPC only, 5 wt.% Cu–nHA/CPC, and 10 wt.% Cu–nHA against (<b>a</b>) <span class="html-italic">S. aureus</span> and (<b>b</b>) <span class="html-italic">E. coli</span> cultured for 4 days. * Indicates that the groups were significantly different (<span class="html-italic">p</span> &lt; 0.05) based on one-way ANOVA (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 3
<p>Injectability and anti-dispersibility in ddH<sub>2</sub>O were observed in time, 1 h, and 24 h after the addition of 5 wt.% Cu–nHA/CPC and 10 wt.% Cu–nHA/CPC composites compared with CPC only.</p>
Full article ">Figure 4
<p>(<b>a</b>) Cu–nHA microimages and (<b>b</b>) the morphology and Cu element mapping (green dots) of fracture surfaces were compared among groups of 5 wt.% Cu–nHA/CPC, 10 wt.% Cu–nHA/CPC, and CPC only after soaking in Tris buffer solution for 1 day.</p>
Full article ">Figure 5
<p>Cytotoxicity of 5 wt.% Cu–nHA/CPC, 10 wt.% Cu–nHA/CPC, and CPC-only extracts was compared to evaluate their effect on L929 cells after 1 day and 3 days of culture. Quantitative (<b>a</b>) and qualitative (<b>b</b>) measurements were taken. The red line indicates that if the cell viability is less than 70% compared to the control, the substance extract is toxic to the cells.</p>
Full article ">Figure 6
<p>Optical images of cell migration after culturing HUVECs with nHA/CPC composite extract of nHA with or without Cu<sup>2+</sup> doping for 6, 12, and 24 h.</p>
Full article ">Figure 7
<p>After a 6 h culture of HUVECs with nHA/CPC composite extracts, angiogenesis was assessed through optical (<b>a</b>) and fluorescence staining (<b>b</b>), with or without Cu<sup>2+</sup> doping.</p>
Full article ">Figure 8
<p>Evaluations were conducted to compare the long-term proliferation ability (<b>a</b>), absorbance value at OD<sub>405</sub> (<b>b</b>), and ALP semi-quantitative analysis (<b>c</b>) of nHA nanoparticles with or without Cu<sup>2+</sup> doping composite to CPC in contact culture with D1 cells; * indicates one-way ANOVA of groups, with <span class="html-italic">p</span> &lt; 0.05 indicating significant difference (<span class="html-italic">n</span> = 6).</p>
Full article ">Figure 9
<p>Qualitative ALP staining was performed on the surfaces of nHA/CPC composite samples with nHA, with or without Cu<sup>2+</sup> doping, followed by contact culture with D1 cells for 1–14 days.</p>
Full article ">
Back to TopTop